Company Procyon Corporation

PCYN

US7428063009

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:08:33 22/06/2024 am IST			5-day change	1st Jan Change
0.294 ^USD	+39.53%		+16.07%	+72.43%

24/05	Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
22/02	Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Procyon Corporation operates through its subsidiaries AMERX Health Care Corporation (AMERX) and Sirius Medical Supply, Inc. (Sirius). AMERX develops and markets proprietary medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder and Collagen Matrix. Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

USD in Million	2022	Weight	2023	Weight	Delta
Proprietary Medical Products 100.0 %	5	100.0 %	5	100.0 %	-3.22%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	5	100.0 %	5	100.0 %	-3.22%

Managers	Title	Age	Since
Justice Anderson CEO	Chief Executive Officer	47	01/06/01
Regina Anderson CHM	Chairman	77	01/05/01
James Anderson DFI	Director of Finance/CFO	54	01/96/01

Members of the board	Title	Age	Since
Justice Anderson CEO	Chief Executive Officer	47	01/06/01
James Anderson DFI	Director of Finance/CFO	54	01/96/01
Regina Anderson CHM	Chairman	77	01/05/01
Fred Suggs BRD	Director/Board Member	77	01/95/01
Joseph Treshler BRD	Director/Board Member	71	01/13/01
Monica McCullough BRD	Director/Board Member	53	11/19/11
Steven McComas BRD	Director/Board Member	57	17/21/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	8,108,388	2,800,936 ( 34.54 %)	0	34.54 %
Stock B	0	166,900	0	0

Name	Equities	%	Valuation
Justice Anderson 42.25 %	3,425,500	42.25 %	866 652 $
Richard M Speer 18.01 %	1,460,000	18.01 %	369 380 $
Fred Suggs 1.542 %	125,000	1.542 %	31 625 $
George O. Borak 1.234 %	100,092	1.234 %	25 323 $
James Anderson 0.9990 %	81,000	0.9990 %	20 493 $
Regina Anderson 0.9627 %	78,060	0.9627 %	19 749 $
Joseph Treshler 0.3083 %	25,000	0.3083 %	6 325 $
Monica McCullough 0.0888 %	7,200	0.0888 %	1 822 $
Steven McComas 0.0691 %	5,600	0.0691 %	1 417 $

Procyon Corp.

164 Douglas Road

34677, Oldsmar

http://www.procyoncorp.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
PROCYON CORPORATION	+72.43%	23.87L
ELI LILLY AND COMPANY	+51.63%	80TCr
NOVO NORDISK A/S	+41.51%	63TCr
JOHNSON & JOHNSON	-5.10%	36TCr
MERCK & CO., INC.	+19.90%	33TCr
ABBVIE INC.	+9.95%	30TCr
ASTRAZENECA PLC	+17.66%	24TCr
ROCHE HOLDING AG	+3.39%	23TCr
NOVARTIS AG	+10.75%	21TCr
AMGEN INC.	+6.99%	17TCr

Other Pharmaceuticals